Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death

Free Radical Biology and Medicine

Volumn 34, Issue 8, 2003, Pages 1100-1110

  Jang, Jung Hee ^a   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

Author keywords

Apoptosis; Beta amyloid; Free radicals; NF B; Oxidative stress; PC12 cells; Reactive oxygen intermediates; Resveratrol

Indexed keywords

AMYLOID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; RESVERATROL; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

VITACEAE;

EID: 0037446328     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00062-5     Document Type: Article

References (67)

1. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
2. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399:1999;A23-A31.
3. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1985;4245-4249.
4. Hardy J.A., Higgins G.A. Alzheimer's disease the amyloid cascade hypothesis . Science. 256:1992;184-185.
5. Selkoe D.J. Alzheimer's disease genes, proteins, and therapy . Physiol. Rev. 81:2001;741-766.
6. Yankner B.A., Dawes L.R., Fisher S., Villa-Komaroff L., Oster-Granite M.L., Neve R.L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 245:1989;417-420.
7. Pike C.J., Walenzcewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
8. Varadarajan S., Yatin S., Aksenova M., Butterfield D.A. Review Alzheimer's amyloid-β peptide-associated free radical oxidative stress and neurotoxicity . J. Struct. Biol. 130:2000;184-208.
9. Miranda S., Opazo C., Larrondo L.F., Munoz F.J., Ruiz F., Leighton F., Inestrosa N.C. The role of oxidative stress in the toxicity induced by amyloid-β peptide in Alzheimer's disease. Prog. Neurobiol. 62:2000;633-648.
10. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
11. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol a molecule whose time has come? And gone? Clin. Biochem. 30:1997;91-113.
12. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
13. Surh Y.-J. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428:1999;305-327.
14. Renaud D., DeLorgeril M. Wine, alcohol, and the French paradox for coronary heart disease. Lancet. 339:1992;1523-1526.
15. Sun A.Y., Simonyi A., Sun G.Y. The "French Paradox" and beyond neuroprotective effects of polyphenols . Free Radic. Biol. Med. 32:2002;314-318.
16. Jung Y.-J., Surh Y.-J. Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid. Free. Radic. Biol. Med. 30:2001;1407-1417.
17. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
18. Halliwell B., Gutteridge J.M.C. Oxygen radicals and the nervous system. Trends Neurosci. 6:1985;22-26.
19. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid-β protein toxicity. Cell. 77:1994;817-827.
20. Loo D.T., Copani A., Pike C.J., Whittemore E.K., Walencewicz A.J., Cotman C.W. Apoptosis is induced by β-amyloid in cultured neuronervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
21. Hensley K., Aksenova M., Carney J.M., Butterfield D.A. Amyloid-β peptide spin trapping II evidence for decomposition of the PBN spin adduct . Neuroreport. 6:1995;489-493.
22. Bowen D.M., Francis P.T., Sims N.R. Beta-amyloid increased neuronal susceptibility to injury by glucose deprivation. Neuroreport. 3:1992;733-734.
23. Klegeris A., McGeer P.L. Beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J. Neurosci. Res. 49:1997;229-235.
24. Behl C., Davis J., Cole G.M., Schubert D. Vitamin E protects nerve cells from amyloid-β protein toxicity. Biochem. Biophys. Res. Commun. 186:1992;944-950.
25. Pappolla M.A., Sos M., Omar R.A., Bick R.J., Hickson-Bick D.L., Reiter R.J., Efthimiopoulos S., Robakis N.K. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17:1997;1683-1690.
26. Shearman M.S., Ragan C.I., Iversen L.L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA. 91:1994;1470-1474.
27. Draczynska-Lusiak B., Chen Y.M., Sun A.Y. Oxidized lipoproteins activate NF-κB binding activity and apoptosis in PC12 cells. Neuroreport. 9:1998;527-532.
28. Das D.K., Sato M., Ray P.S., Maulik G., Engelman R.M., Bertelli A.A., Bertelli A. Cardioprotection of red wine role of polyphenolic antioxidants . Drugs Under Exp. Clin. Res. 25:1999;115-120.
29. Sinha K., Chaudhary G., Kumar Gupta Y. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci. 71:2002;655-665.
30. Wood K.A., Youle R.J. Apoptosis and free radicals. Ann. NY Acad. Sci. 17:1994;400-407.
31. Slater A.F., Nobel C.S., Orrenius S. The role of intracellular oxidants in apoptosis. Biochem. Biophys. Acta. 1271:1995;59-62.
32. Sato M., Bagchi D., Tosaki A., Das D.K. Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and c-JUN. Free Radic. Biol. Med. 31:2001;729-737.
33. Kang C.D., Jang J.H., Kim K.W., Lee H.J., Jeong C.S., Kim C.M., Kim S.H., Chung B.S. Activation of c-jun N-terminal kinase/stress-activated protein kinase and the decreased ratio of Bcl-2 to Bax are associated with the autoxidized dopamine-induced apoptosis in PC12 cells. Neurosci. Lett. 25:1998;37-40.
34. Yoshizumi M., Kogame T., Suzaki Y., Fujita Y., Kyaw M., Kirima K., Ishizawa K., Tsuchiya K., Kagami S., Tamaki T. Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signaling pathway in PC12 cells. Br. J. Pharmacol. 136:2002;1023-1032.
35. Bozyczko-Coyne D., O'Kan T.M., Wu Z.L., Dobrzanski P., Murthy S., Vaught J.L., Scott R.W. CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Aβ-induced cortical neuron apoptosis. J. Neurochem. 77:2001;849-863.
36. Anderson A.J., Su J.H., Cotman C.W. DNA damage and apoptosis in Alzheimer's disease colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay . J. Neurosci. 16:1996;1710-1719.
37. Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M., Miyazono K., Ichijo H. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell. 2:1998;389-395.
38. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17:1998;2596-2606.
39. Tobiume K., Saitoh M., Ichijo H. Activation of ASK1 by the stress-induced activating phosphorylation of preformed oligomer. J. Cell. Physiol. 191:2002;95-104.
40. Nishitoh H., Matsuzawa A., Tobiume K., Saegusa K., Takeda K., Inoue K., Hori S., Kakizuka A., Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 16:2002;1345-1355.
41. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor κB an oxidative stress-responsive transcription factor of eukaryotic cells . Free Radic. Res. Commun. 17:1992;221-237.
42. Ginn-Pease M.E., Whisler R.L. Redox signals and NF-κB activation in T cells. Free Radic. Biol. Med. 25:1998;346-361.
43. Xu J., Chen S., Ahmed S.H., Chen H., Ku G., Goldberg M.P., Hsu C.Y. Amyloid-β peptides are cytotoxic to oligodendrocytes. J. Neurosci. 21:2001;RC118.
44. Kang J., Park E.J., Jou I., Kim J.H., Joe E.H. Reactive oxygen species mediate Aβ(25-35)-induced activation of BV-2 microglia. Neuroreport. 12:2001;1449-1452.
45. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
46. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells AP-1 as secondary antioxidant-responsive factor . EMBO J. 12:1993;2005-2015.
47. Jang J.-H., Surh Y.-J. Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutat. Res. 496:2001;181-190.
48. Manna S.K., Mukhopadhyay A., Aggarwal B.B. Resveratrol suppresses activation of TNF-induced nuclear transcription factors NF-κB, activator protein-1, and apoptosis potential role of reactive oxygen intermediates and lipid peroxidation . J. Immunol. 164:2000;6505-6519.
49. Tsai S.H., Lin-Shiau S.Y., Lin J.K. Suppression of nitric oxide synthase and the downregulation of the activation of NF-κB in macrophages by resveratrol. Br. J. Pharmacol. 126:1999;673-680.
50. Holmes-McNary M., Baldwin A.S. Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res. 60:2000;3477-3483.
51. Maccarrone M., Lorenzon T., Guerrieri P., Agro A.F. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur. J. Biochem. 265:1999;27-34.
52. Nicolini G., Rigolio R., Scuteri A., Miloso M., Saccomanno D., Cavelleti G., Tredici G. Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem. Int. 42:2003;419-429.
53. Surh Y.J., Hurh Y.J., Kang J.Y., Lee E., Kong G., Lee S.J. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 140:1999;1-10.
54. Clement M.V., Hirpara J.L., Chawdhury S.H., Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood. 92:1998;996-1002.
55. She Q.B., Huang C., Zhang Y., Dong Z. Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis. Mol. Carcinog. 33:2002;244-250.
56. Joe A.K., Liu H., Suzui M., Vural M.E., Xiao D., Weinstein I.B. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 28:2002;893-903.
57. Lin H.Y., Shih A., Davis F.B., Tang H.Y., Martino L.J., Bennett J.A. Resveratrol-induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J. Urol. 168:2002;748-755.
58. Ding X.Z., Adrian T.E. Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas. 25:2002;e71-e76.
59. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273:1998;21875-21882.
60. Bhat K.P., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Ann. NY Acad. Sci. 957:2002;210-229.
61. Mutoh M., Takahashi M., Fukuda K., Matsushima-Hibiya Y., Mutoh H., Sugimura T., Wakabayashi K. Supression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis. 21:2000;959-963.
62. Li Z.G., Hong T., Shimada Y., Komoto I., Kawabe A., Ding Y., Kagan J., Hashimoto Y., Imamura M. Supression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis. 23:2002;1531-1536.
63. Miura T., Muraoka S., Ikeda N., Watanabe M., Fujimoto Y. Antioxidative and pro-oxidative action of stilbene derivatives. Pharmacol. Toxicol. 86:2000;203-208.
64. Win W., Cao Z., Peng X., Trush M.A., Li Y. Different effects of genistein and resveratrol on oxidative DNA damage in vitro. Mutat. Res. 513:2002;113-120.
65. Ahmad A., Farhan Asad S., Singh S., Hadi S.M. DNA breakage by resveratrol and Cu(II) reaction mechanism and bacteriophage inactivation . Cancer Lett. 154:2000;29-37.
66. Fukuhara K., Miyata N. Resveratrol as a new type of DNA-cleaving agent. Bioorg. Med. Chem. Lett. 8:1998;3187-3192.
67. Burkitt M.J., Dunkan J. Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action . Arch. Biochem. Biophys. 381:2000;253-263.